Northern Trust’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Northern Trust’s Portfolio ASPX Stock Details ASPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-126,778	Closed	-$12.7M	–	4347
2015 Q1	$12.7M	Buy	126,778 +22,774	+22%	+$1.52M	﹤0.01%	1920
2014 Q4	$5.46M	Sell	104,004 -2,786	-3%	-$81.8K	﹤0.01%	2453
2014 Q3	$2.74M	Buy	106,790 +10,669	+11%	+$227K	﹤0.01%	2892
2014 Q2	$2.14M	Buy	96,121 +63,756	+197%	+$1.39M	﹤0.01%	3052
2014 Q1	$996K	Buy	+32,365	New	+$870K	﹤0.01%	3399

Northern Trust's ASPX Position: Q2 2015 in Review

Northern Trust sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 126,778 shares — an estimated $12.7M sold.

Northern Trust first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $12.7M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

Northern Trust reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Northern Trust sold 126,778 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $12.7M.
Northern Trust first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
Northern Trust's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $12.7M in Q1 2015.
0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Northern Trust's 13F filing for Q2 2015, filed 13 Aug 2015.